Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Phosphate Binder [EPC]

Known as: Phosphate Binder 
 
National Institutes of Health

Related topics

Related topics

2 relations
Phosphate BindersPhosphate Chelating Activity [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats.
Although magnesium has been shown to prevent vascular calcification in vitro, controlled in vivo studies in uremic animal models… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2017
2017
Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
AIMS Hyperphosphatemia has been associated with an increased risk of mortality in patients with end-stage renal disease. We… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Review
2016
Review
2016
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Mineral and bone disorder is a common complication of end-stage renal disease. Notably, hyperphosphatemia likely promotes… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Dose–response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study
BackgroundHyperphosphatemia is common in chronic kidney disease (CKD) and associated with mortality and morbidity. We aimed to… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2015
2015
Probing the compatibility of energetic binder poly-glycidyl nitrate with energetic plasticizers: thermal, rheological and DFT studies
The essential idea of developing energetic binders and plasticizers is to enhance the thermal stability and energy content… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2015
2015
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
BACKGROUND Phosphate binders are the cornerstone of hyperphosphatemia management in dialysis patients. Ferric citrate is an iron… Expand
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
2014
2014
A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis.
BACKGROUND JTT-751 is a novel phosphate binder containing ferric citrate as the active ingredient. METHODS In this Phase 3… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study
BACKGROUND Different phosphate binders exert differing effects on bone mineral metabolism and levels of regulating hormones. The… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2013
2013
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
BackgroundDespite the evidence that phosphate binder (PB) is associated with improved outcomes many hemodialysis patients do not… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction
BACKGROUND The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE